Search

If we can edit RNA at the kilobase scale, we can treat more diseases at the genetic level

How pharmaceutical companies are aligning their sustainability goals with the complexities of the modern supply chain

Experts discuss the most exciting Alzheimer’s Disease treatment trends – and make bold predictions for the future

Here’s how paper is weighing down the future of advanced therapies.

Progress in Alzheimer’s Disease research, but a cure will take time. Delaying it and disseminating that research may buy scientists the time they need

How – and why – we are tackling opioid use disorder with a monoclonal antibody

Biopharma tech continues to advance so why is downstream processing such a headache?

Why the FDA must delete its statement that people are not horses (or cows), referring to ivermectin use

Looking at key milestones, challenges, and innovations in cell culture media – and what lies in store ahead.

Diseases can affect men and women differently. We must acknowledge and accept that – and then optimize drug development accordingly